Consumer News Are Major Insurers Trying To Lower Your Drug Costs
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Are Major Insurers Trying To Lower Your Drug Costs is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Big Pharma’s Profits Hit Hard as Medicare Slashes 15 Drug Prices by 71%

The U.S. government has finished its second round of drug price negotiations, reaching major discounts on 15 widely used prescription drugs. Some prices will drop by as much as 85 percent. This is a ... Read More
Why your health insurance premiums keep rising

Health care costs are rising due to higher hospital prices, drug costs, and administrative expenses. More people are using medical services as delayed pandemic care catches up. Insurers are adjusting ... Read More
Health and Human Services Department announces plans for lower drug costs

The Health and Human Services Department (HHS) will hold a news conference “to announce major actions to lower drug costs.” Participants include HHS Secretary Robert F. Kennedy Jr.; FDA Commissioner ... Read More
Experts: SC could benefit from Trump negotiating lower drug costs

COLUMBIA, S.C. (WSPA) – President Donald Trump is working on a deal with major pharmaceutical companies, including Pfizer, to lower the cost of prescription drugs. Health policy experts believe the ... Read More
Trump’s lower drug price push comes at a cost — here’s an alternative

On Oct. 1, Pfizer agreed to lower the prices of some drugs in response to President Donald Trump’s executive order on most favored nation drug pricing. The order threatens drugmakers who don’t reduce ... Read More
Trump unveils deal to expand coverage and lower costs on obesity drugs

WASHINGTON — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus

